Author

R Nakashima

Observed name: R. Nakashima

Institution: American Society for Clinical Pathology

Observed institutions: Kanazawa University, Osaka Rosai Hospital, Osaka University Hospital, The Ohio State University, American Society for Clinical Pathology, The University of Osaka

OpenAlex ID: A5111871453

Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.

1997 · H Wada, T Enomoto, et al. · PubMed · 197

Alteration of p16 and p15 genes in human uterine tumours

1999 · R Nakashima, M Fujita, et al. · British Journal of Cancer · 95

Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.

1998 · M A Lynch, R Nakashima, et al. · PubMed · 87

Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract

1995 · T Enomoto, M Fujita, et al. · British Journal of Cancer · 41

Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma.

1999 · R Nakashima, H Song, et al. · Europe PMC (PubMed Central) · 16

Clonality and HPV Infection Analysis of Concurrent Glandular and Squamous Lesions and Adenosquamous Carcinomas of the Uterine Cervix

2008 · Y Ueda, T Miyatake, et al. · Journal of Lower Genital Tract Disease · 2

The von-Hippel-Lindau (VHL) tumor suppressor gene is not mutated in sporadic ovarian carcinomas

1996 · R Nakashima, T Enomoto, et al. · Oncology Reports · 1

506 The Second Line Chemotherapy for The Ovarian Carcinoma After The First Line Chemotherapy With The Combination of Paclitaxel and Carboplatin

2004 · R. Nakashima, T. Enomoto, et al. · International Journal of Gynecological Cancer

Works count: 8

Citation count: 439

H-index: 5

I10-index: 5